Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
NDA remains on track for FDA PDUFA goal date of January 31, 2026Commercial planning continues enabling rapid launch following approval WARREN, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Aquestive...
-
Industry veterans David R. Epstein and Michael A. Margolis have been appointed as members of Cancer Focus Fund's Investment Committee Advisory Board.
-
MONTRÉAL, 04 sept. 2025 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (la « Société » ou « Métaux Osisko ») (TSX : OM; OTCQX : OMZNF; FRANKFURT : 0B51) a le plaisir d’annoncer de nouveaux...
-
Osisko Metals announces new drill results from the Gaspé Copper Project, located in the Gaspé Peninsula of Eastern Québec.
-
Montpellier, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Montpellier, September 4th 2025 – Quantum Surgical has obtained CE mark approval for the expanded use of its Epione® robotic platform in the...
-
CHICAGO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The American Medical Association (AMA) today named 109 hospitals, health systems and medical groups that have earned national distinction in 2025 as Joy...
-
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- SOUTH SAN FRANCISCO, Calif., September 2, 2025 — Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range...
-
Dublin, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The "Cancer Biopsy Market by Product Type (Core Needle Biopsy, Fine Needle Aspiration, Surgical Biopsy), Application (Breast, Liver, Lung), Technology, End...
-
CHICAGO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- With summer vacations behind us and the year-end rapidly approaching, Third Road Management, a pioneer in the booming fractional financial services...
-
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant...